Coronavirus Rheumatoid arthritis drug could help treat covid-19

Rheumatoid arthritis drug could help treat covid-19

The pharmaceutical company Eli Lilly announced that the combination of its rheumatoid arthritis treatment baricitinib with remdesivir reduced the recovery time in hospitalized patients with covid-19.

Eli Lilly explained that during the Adaptive Covid-19 Treatment Trial (ACTT-2), the researchers observed a reduction of approximately one day in the mean recovery time of patients treated with baricitinib combined with the substance remdesivir, compared to those who they were only treated with remdesivir, which is why they rated the finding as statistically significant.

The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institute of Health (NIH), included more than 1,000 patients and began on May 8 to evaluate the efficacy and safety of a dose. of 4 mg baricitinib plus remdesivir versus remdesivir in hospitalized patients with COVID-19.

According to Eli Lilly, the combination met the primary endpoint of reduced recovery time, which was defined as that the participant was well enough for discharge from hospital, meaning that they no longer needed supplemental oxygen or care continued in the hospital, or was no longer hospitalized on the 29th.

Eli Lilly reported that additional analysis is underway to understand other clinical outcome data, including mortality and safety data, and that NIAID is expected to publish full details of the study in a peer-reviewed journal.

Eli Lilly said he plans to discuss the emergency use authorization of the combination with the US Food and Drug Administration (FDA) and explore similar measures with other regulatory agencies for baricitinib as a treatment. of hospitalized patients with covid-19. If authorized, the company will propose that baricitinib be available through commercial channels and will work with hospitals and governments to ensure patient access.

Matthew Leisinghttps://www.newsalarms.com/
I cover market structure for News Alarms, specifically how the bond, derivatives, and cryptocurrency markets work or don't.

Latest news

The Bank of Russia intends to discuss with the market the commission for transfers in digital rubles

The regulator plans to discuss the concept of the digital ruble with the market by June, then it will...

Coinbase crypto exchange was valued at $ 100 billion: it is more expensive than Nasdaq, CME, ICE or CBOE

Today, Coinbase is valued at more than double the $ 43 billion Nasdaq, CME, ICE, or CBOE mid-cap. Last week,...

Bellabeat Launches Corporate Wellness Program

When most of us think of our jobs, a few things come to mind like late hours, constant emails,...

Eve Jobs, the modeling debut of Steve Jobs’ daughter

The youngest daughter of the great tech-guru and founder of Apple is the testimonial of a Gen Z beauty...

5 skincare mistakes that make you look older

Taking care of your skin is a basic step that you must take in your daily routine, regardless of your age,...

The 72-hour rule helps you in implementing your plans

If you want to implement a project, you shouldn't wait too long: If you don't get started within three...

Must read

You might also like
Recommended to you